Image

Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Pilot Diagnostic Accuracy Study

Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Pilot Diagnostic Accuracy Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Quality improvement study with prospective observational design. The study explores the feasibility of testing diagnostic accuracy of an emergency department-performed focused ultrasound scan of the popliteal fossa in detecting symptomatic Baker's cysts, and to evaluate the potential for such follow-ups to conserve radiological resources. Ultimately, this work aims to establish the feasibility and provide the foundational data necessary for a future definitive diagnostic accuracy study.

Description

Patients with suspected deep vein thrombosis (DVT) are commonly evaluated using clinical probability assessment, D-dimer testing, and compression ultrasonography. However, a substantial proportion of patients referred for DVT evaluation are ultimately diagnosed with alternative conditions that may explain their symptoms. One such condition is a symptomatic Baker's cyst, which may present with unilateral leg pain, swelling, or discomfort that clinically mimics DVT.

In current clinical practice, radiologist-performed complete compression ultrasound of the lower extremity (CCUS) is primarily used to confirm or exclude DVT. Although Baker's cysts are frequently identified during these examinations, their potential role as an early alternative diagnosis within the diagnostic pathway has not been systematically investigated. A focused ultrasound examination of the popliteal fossa (FUP) may allow emergency department (ED) or primary care clinicians to identify symptomatic Baker's cysts before referral for further DVT workup.

This prospective pilot study primarily aims to evaluate the feasibility of conducting a future definitive study investigating the role of FUP in patients with suspected DVT. Key feasibility outcomes include recruitment rates, scan completion rates, workflow integration, procedure timing, and practical implementation within routine emergency care. In addition, the study will generate preliminary diagnostic accuracy estimates regarding the ability of ED physicians and trained research assistants to identify symptomatic Baker's cysts using FUP, with CCUS serving as the reference standard. These data will be used to estimate outcome variance and inform sample size calculations and study design for a future definitive validation study.

This single-center pilot study will be conducted at Aarhus University Hospital, Denmark, among adult patients referred to the ED with suspected DVT. All participants will receive standard diagnostic evaluation and management according to current guidelines. The study-specific FUP examination will be performed before D-dimer and/or CCUS results are available, and FUP findings will not influence clinical decision-making during the study.

Eligibility

Inclusion Criteria:

  • Age ≥ 18 years
  • Clinical signs and symptoms of DVT, prompting the treating physician to initiate d-Dimer or CCUS diagnostic strategies

Exclusion Criteria:

  • Prior inclusion
  • FUP performed following d-Dimer or CCUS result already revealed

Study details
    Baker's Cyst

NCT07791017

Aarhus University Hospital

29 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.